Jilin OLED(688378)
Search documents
奥来德:子公司与成都京东方签订6.55亿元销售合同
WitsView睿智显示· 2025-05-07 09:58
Core Viewpoint - The announcement by Jilin Aolide Optoelectronic Materials Co., Ltd. regarding a significant contract signed by its wholly-owned subsidiary, Shanghai Shengxi Optoelectronics Technology Co., Ltd., with Chengdu BOE Display Technology Co., Ltd. is expected to enhance the company's operational performance and brand influence in the 8.6-generation evaporation source market [1]. Group 1 - The contract amount for the supply of linear evaporation sources is 655,400,000.00 yuan [1]. - The contract is anticipated to positively impact the company's performance in the fiscal years 2025 and 2026, although there may be delays in revenue recognition [1]. - Chengdu BOE was established in 2022 and is primarily owned by BOE Technology Group Co., Ltd., focusing on technology services and manufacturing of display devices [1]. Group 2 - Shengxi Optoelectronics, founded in 2015, specializes in high-generation AMOLED evaporation source systems, significantly improving production yield from single digits to over 90% [2]. - Aolide's main business includes the research, production, and sales of organic light-emitting materials and evaporation source equipment, with applications in OLED displays and lighting [2].
化工行业2025年中期投资策略:厚积薄发,化工周期新起点
KAIYUAN SECURITIES· 2025-05-07 02:23
Investment Rating - The report indicates a positive outlook for the chemical industry, suggesting a new cycle may begin due to improved domestic supply and demand, increased global market share, and declining crude oil prices [3][4]. Core Viewpoints - The chemical industry is expected to enter a new cycle driven by domestic supply-demand improvements and global market share growth, despite potential short-term impacts from overseas demand [3][5]. - The report highlights that the supply side is gradually improving due to reduced fixed asset investment growth and government policies aimed at curbing excessive competition [5][10]. - On the demand side, domestic consumption is anticipated to recover steadily, supported by government initiatives to boost consumption and stabilize the economy [26][33]. - Cost factors are favorable, with significant declines in international crude oil and domestic coal prices, which will support the profitability of chemical products [42][49]. - The report recommends specific companies within various segments of the chemical industry, including refrigerants, amino acids, military and new materials, and fertilizers, indicating potential investment opportunities [5][57]. Summary by Sections Supply Side - The report notes that the chemical industry has faced profitability pressures since 2022, but the current production cycle is nearing its end, which may lead to gradual improvement in profitability as capacity is digested [11][12]. - China's global market share in chemical products has been steadily increasing, with 2023 figures showing a 43.1% share of global sales [25][20]. Demand Side - The report emphasizes that domestic demand is expected to recover, aided by government policies aimed at stimulating consumption and investment [26][33]. - The real estate sector shows signs of stabilization, which could further support demand for chemical products [33]. Cost Side - The report highlights a significant decline in crude oil prices, with Brent crude falling by 14.71% since the beginning of 2025, which is expected to positively impact the cost structure of the chemical industry [42][38]. - Domestic coal and natural gas prices have also shown a downward trend, enhancing the cost competitiveness of chemical products [49][47]. Valuation - The report indicates that the valuation of the basic chemical and petrochemical sectors is at historical lows, suggesting substantial room for recovery as market conditions improve [54][50].
奥来德(688378) - 广发证券股份有限公司关于吉林奥来德光电材料股份有限公司2024年度持续督导跟踪报告
2025-04-30 15:46
广发证券股份有限公司 关于吉林奥来德光电材料股份有限公司 2024 年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市 规则》等有关法律、法规的规定,广发证券股份有限公司(以下简称"广发证券"、 "保荐机构")作为吉林奥来德光电材料股份有限公司(以下简称"奥来德"、 "公司") 2022 年度向特定对象发行股票的持续督导保荐机构,负责奥来德的 持续督导工作,并出具本年度持续督导跟踪报告。 2024 年度,广发证券对奥来德的持续督导工作情况总结如下: | 序号 | 工作内容 | 实施情况 | | --- | --- | --- | | | 建立健全并有效执行持续督导工作制度,并 | 保荐机构已建立健全并有效执行 | | 1 | 针对具体的持续督导工作制定相应的工作计 | 了持续督导制度,已制定了相应的 | | | 划。 | 工作计划。 | | | 根据中国证监会相关规定,在持续督导工作 | 保荐机构已与奥来德签订《保荐协 | | | 开始前,与上市公司或相关当事人签署持续 | 议》,该协议已明确了双方在持续 | | 2 | 督导协议,明确双方在持续督导期间的权利 | 督导期 ...
奥来德(688378) - 吉林奥来德光电材料股份有限公司章程(2025年4月)
2025-04-30 15:44
吉林奥来德光电材料股份有限公司 章程 吉林奥来德光电材料股份有限公司 章 程 二零二五年 | 第一节 | 股份发行 | | 5 | | --- | --- | --- | --- | | 第二节 | 股份增减和回购 | | 6 | | 第三节 | 股份转让 | | 7 | | 第一节 | 股东的一般规定 | | 8 | | 第二节 | 控股股东和实际控制人 | | 12 | | 第三节 | 股东会的一般规定 | | 13 | | 第四节 | 股东会的召集 | | 16 | | 第五节 | 股东会的提案与通知 | | 18 | | 第六节 | 股东会的召开 | | 19 | | 第七节 | 股东会的表决和决议 | | 22 | | 第一节 | 董事的一般规定 | | 27 | | 第二节 | 董事会 | | 31 | | 第三节 | 独立董事 | | 38 | | 第四节 | 董事会专门委员会 | | 42 | | 第一节 | 财务会计制度 | | 46 | | 第二节 | 内部审计 | | 51 | | 第三节 会计师事务所的聘任 52 | | --- | | 第八章 通知和公告 | | 第一节 通知 52 ...
公告精选丨江波龙:国家集成电路产业基金拟减持不超过1%公司股份;海天味业:公司H股发行上市已获中国证监会备案
2 1 Shi Ji Jing Ji Bao Dao· 2025-04-30 14:38
Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]
晚间公告丨4月30日这些公告有看头
第一财经· 2025-04-30 13:27
Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets have announced significant updates, including stock suspensions, name changes, and financial adjustments, which may present both opportunities and risks for investors [4][5][8][10]. Group 1: Stock Suspension and Changes - ST Xinchao will suspend its stock from May 6, 2025, due to the inability to disclose audited financial reports within the legal timeframe, with a risk of delisting if reports are not provided within two months [4]. - Wolong Real Estate plans to change its stock name to "Wolong New Energy" to align with national carbon neutrality policies and explore new profit growth areas [5]. Group 2: Financial and Operational Updates - Dongzhu Ecology clarified that it holds only a 10% stake in Dilos AI Technology and has no substantial business cooperation with it, indicating potential uncertainties in future performance [6][7]. - Haitian Flavor Industry has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue up to 710.52 million shares for overseas listing, though uncertainties remain [8]. - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection, which generated approximately RMB 210 million in sales in 2024, accounting for 29% of total revenue, potentially leading to losses in 2025 [10]. Group 3: Shareholding and Financing Activities - Jiangbolong's major shareholder, the National Integrated Circuit Industry Investment Fund, plans to reduce its stake by up to 1% through market transactions between May 27 and August 26, 2025, without affecting control [12][13]. - Cambrian Technology intends to raise no more than RMB 4.98 billion through a private placement to fund projects related to large model chip and software platforms and to supplement working capital [14]. - Jinzhen Co. plans to sell up to 5 million shares from its repurchased stock, which amounts to 50% of the total repurchased shares, to maintain company value and shareholder interests [15]. Group 4: Major Contracts and Procurement Wins - Aolaide's subsidiary signed a sales contract worth RMB 655 million with Chengdu BOE Display Technology, expected to positively impact the company's performance in 2025 and 2026 [16]. - Tongguang Cable is a candidate for two procurement projects from the State Grid Corporation, with a total expected bid amount of RMB 142 million, representing approximately 5.49% of the company's total revenue for 2024 [17].
奥来德(688378) - 关于召开2024年年度股东大会的通知
2025-04-30 11:08
证券代码:688378 证券简称:奥来德 公告编号:2025-026 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东大会类型和届次 2024年年度股东大会 (二) 股东大会召集人:董事会 (三) 投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 召开日期时间:2025 年 5 月 22 日 14 点 30 分 召开地点:长春市高新开发区红旗大厦 19 层公司会议室 吉林奥来德光电材料股份有限公司 关于召开2024年年度股东大会的通知 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自2025 年 5 月 22 日 至2025 年 5 月 22 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 股东大会召开日期:2025年5月22日 本次股东大会采用的网络投票系统:上海证券交易所股东大会网络投票 系统 东大会召开当日的交易 ...
奥来德(688378) - 信息披露管理制度
2025-04-30 11:01
吉林奥来德光电材料股份有限公司 信息披露管理制度 吉林奥来德光电材料股份有限公司 信息披露管理制度 二零二五年 吉林奥来德光电材料股份有限公司 信息披露管理制度 第一章 总则 第一条 为规范吉林奥来德光电材料股份有限公司(以下简称"本公司"或 "公司")的信息披露行为,确保公司信息披露的真实、准确、完整与及时,切 实保护公司、股东及投资者的合法权益,依照《公司法》《证券法》《上海证券 交易所科创板股票上市规则》(以下简称"《上市规则》")、《科创板上市公 司持续监管办法(试行)》《上市公司信息披露管理办法》及《吉林奥来德光电 材料股份有限公司章程》(以下简称"《公司章程》")等,制定本制度。 第二条 本制度所称"信息披露义务人"除公司本身外还包括: (一)公司董事和高级管理人员; (二)公司核心技术人员; (三)公司股东、实际控制人; (四)收购人及其相关人员; (五)重大资产重组、再融资、重大交易有关各方等自然人、单位及其相关 人员; (六)破产管理人及其成员; (七)法律、行政法规和中国证监会规定的其他承担信息披露义务的主体。 第二章 信息披露的基本原则 第三条 信息披露是公司的持续性责任。公司应当根据法 ...
奥来德(688378) - 对外担保管理办法
2025-04-30 11:01
第一章 总则 吉林奥来德光电材料股份有限公司 对外担保管理办法 吉林奥来德光电材料股份有限公司 对外担保管理办法 二零二五年 吉林奥来德光电材料股份有限公司 对外担保管理办法 第一条 为了保护投资人的合法权益,规范吉林奥来德光电材料股份有限公 司(以下简称"公司")的对外担保行为,有效防范公司对外担保风险,确保公 司资产安全,促进公司健康稳定发展,根据《民法典》《公司法》《上海证券交易 所科创板股票上市规则》《上市公司监管指引第 8 号——上市公司资金往来、对 外担保的监管要求》等法律、法规、规范性文件及《公司章程》的有关规定,特 制定本管理办法。 第二条 本办法所称对外担保是指公司为他人提供的担保,包括公司对控股 子公司的担保。本办法所称"公司及其控股子公司的对外担保总额",是指包括 公司对控股子公司担保在内的公司对外担保总额与公司控股子公司对外担保总 额之和。 第三条 公司对外担保实行统一管理,非经公司董事会或股东会批准,任何 人无权以公司名义签署对外担保的合同、协议或其他类似的法律文件。 第四条 公司控股子公司对于向公司合并报表范围之外的主体提供担保的, 应视同公司提供担保,其对外担保应执行本制度。 第 ...
奥来德(688378) - 独立董事及审计委员会年报工作制度
2025-04-30 11:01
二零二五年 1 吉林奥来德光电材料股份有限公司 独立董事及审计委员会年报工作制度 为进一步完善公司治理结构,加强内部控制制度建设,夯实信息披露编制工 作的基础,充分发挥独立董事及审计委员会的作用,根据中国证券监督管理委员 会、上海证券交易所及《吉林奥来德光电材料股份有限公司章程》等有关规定制 定本工作制度。 第一条 独立董事及审计委员会应在公司年报编制和披露过程中切实履行 责任和义务,勤勉尽职地开展工作。 第二条 在年度报告编制和审议期间,独立董事及审计委员会委员负有保密 义务。在年度报告披露前,严防泄露内幕信息、内幕交易等违法违规行为发生。 第三条 独立董事应及时听取公司管理层对本年度的生产经营情况和投、融 资活动等重大事项的情况汇报。每一年度公司均应安排独立董事对公司的生产和 经营情况以及重大事项的进展情况进行实地考察。汇报及考察均应有书面记录, 必要的文件应有当事人签字。 吉林奥来德光电材料股份有限公司 独立董事及审计委员会年报工作制度 吉林奥来德光电材料股份有限公司 独立董事及审计委员会年报工作制度 第四条 公司财务部应在年审注册会计师进场审计前向独立董事及审计委员 会书面提交本年度审计工作安排及其他 ...